Showing results (171-180 of 193) with videos related to

Sort By:
Pageof 20
Leukemia|February 1, 1993
Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome predictionG Barosi, A Ambrosetti, A Buratti, et al.
Haematologica|March 7, 2000
A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL)P G Gobbi, M L Ghirardelli, P Avanzini, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1982
New clinical criteria for the assessment of liver involvement in Hodgkin's diseaseP G Gobbi, G A Parrinello, U Di Prisco, et al.
Cancer|April 13, 2001
Comparison of prognostic models in patients with advanced Hodgkin disease. Promising results from integration of the best three systemsP G Gobbi, P L Zinzani, C Broglia, et al.
Hematological Oncology|January 1, 1990
Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapyG Merlini, G A Parrinello, L Piccinini, et al.
Cytometry|April 23, 1999
Fetal erythroblast isolation up to purity from cord blood and their culture in vitroG Sitar, S Garagna, M Zuccotti, et al.
British Journal of Haematology|June 1, 1991
Establishment and characterization of a B-cell line derived from a patient with a myelodysplastic syndrome which expresses myelomonocytic and lymphoid markersG Bergamaschi, C C Stella, G Cattoretti, et al.
Leukemia|October 1, 1991
Tumor necrosis factor alpha modulates the messenger RNA expression of hematopoietic growth factor genes in fresh blast cells from patients with acute myeloblastic leukemiaG Bergamaschi, M Cazzola, V Rosti, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 14, 1997
Membrane CD22 defines circulating myeloma-related cells as mature or later B cellsV Perfetti, M C Vignarelli, V Bellotti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Vinblastine, bleomycin, and methotrexate chemotherapy plus extended-field radiotherapy in early, favorably presenting, clinically staged Hodgkin's patients: the Gruppo Italiano per lo Studio dei Linfomi ExperienceP G Gobbi, C Pieresca, A Frassoldati, et al.
Pageof 20